Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

cord blood-derived CAR T cells

A preparation of umbilical cord blood (CB)-derived T lymphocytes that are genetically engineered to express a chimeric antigen receptor (CAR) that targets an as of yet unidentified tumor-associated antigen (TAA), with potential immunomodulatory and antineoplastic activities. Upon administration of the cord blood derived CAR T cells, the T cells target, bind to and induce selective cytotoxicity in tumor cells expressing the TAA.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	CB-derived CAR T cells cord blood CAR T cells

cord blood-derived CAR T cells

Search NCI's Drug Dictionary